Zobrazeno 1 - 10
of 62
pro vyhledávání: '"35"'
Autor:
Gürsel Çok, Haydar Karakus, Münevver Erdinç, Tuncay Göksel, Erdem Göker, Ozlem Goksel, Feza Bacakoglu, Ruchan Uslu
Publikováno v:
International Journal of Clinical Oncology. 20:395-404
Chemotherapy is one of the main treatments for lung cancer, and in these patients, discontinuation of treatment due to uncontrollable hypersensitivity reactions (HSRs) is an important problem. To determine the frequency of HSRs during chemotherapy an
Publikováno v:
International Journal of Clinical Oncology. 24:1565-1573
Invasive micropapillary carcinoma (IMPC) is a relatively rare subtype of gastric adenocarcinoma and has aggressive histopathologic characteristics, including lymphatic and vascular invasion. However, the associated long-term survival outcomes remain
Autor:
Akiyo Taneichi, Shizuo Machida, Chikako Yoshida, Yoshifumi Takahashi, Suzuyo Takahashi, Shigeki Matsubara, Takahiro Yoshiba, Yasushi Saga, Hiroyuki Fujiwara, Yuji Takei
Publikováno v:
International Journal of Clinical Oncology. 23:930-935
Although there have been several reports regarding the significance of staging lymphadenectomy for early stage ovarian clear cell carcinoma (CCC) patients, there have been few reports focusing on the number of removed lymph nodes. The aim of this stu
Publikováno v:
International Journal of Clinical Oncology. 21:102-109
The prognosis for locally advanced gastric cancer (AGC) remains unsatisfactory, even with S-1 adjuvant chemotherapy. We investigated the efficacy of neoadjuvant chemotherapy consisting of docetaxel, cisplatin and S-1 (DCS).We retrospectively reviewed
Autor:
Hisashi Mitsufuji, Masaru Kubota, Shinichiro Ryuge, Sakiko Otani, Ken Katono, Noriyuki Masuda, Masato Katagiri, Satoshi Igawa, Akira Takakura, Tomoya Fukui, Yuka Kimura, Nobuo Yanase
Publikováno v:
International Journal of Clinical Oncology. 15:447-452
This study was conducted to evaluate the efficacy of amrubicin as first-line chemotherapy for elderly and poor-risk patients with extensive-disease small-cell lung cancer (ED-SCLC).Untreated SCLC patients who were75 years of age or had a performance
Autor:
Taka-Aki Sato, Kazuyuki Fujita, Hiroaki Kase, Minoru Watanabe, Takayuki Amikura, Kenichi Tanaka, Hitoshi Kurata, Yoichi Aoki
Publikováno v:
International Journal of Clinical Oncology. 7:45-50
Background. The purpose of this study was to report the duration of the progression-free interval (PFI) in advanced ovarian cancer patients who were treated with intermittent maintenance chemotherapy. Methods. Between 1991 and 1998, 25 patients with
Publikováno v:
International journal of clinical oncology. 18(1)
The aim of this study was to evaluate the use of sunitinib as third-line therapy for metastatic renal cell carcinoma (mRCC).This study included a total of 35 consecutive Japanese patients with mRCC who were treated with third-line sunitinib after seq
Autor:
Koichi Hirata, Yuji Iwayama, Gentaro Ishiyama, Makoto Meguro, Yasutoshi Kimura, Toshihiko Nishidate, Toru Mizuguchi, Kenji Okita, Tomohisa Furuhata
Publikováno v:
International journal of clinical oncology. 14(5)
The combination of oral uracil/tegafur (UFT) plus leucovorin (LV) is widely accepted as adjuvant chemotherapy for stages II and III of colorectal cancer. However, the clinical compliance of Japanese patients with this regimen has not been clearly elu
Autor:
Masaharu Nishimura, Tetsuya Kojima, Koichi Yamazaki, Fumihiro Hommura, Hiroshi Isobe, Hiroshi Yokouchi, Satoshi Oizumi, Jun Konishi
Publikováno v:
International journal of clinical oncology. 14(2)
Combination chemotherapy comprising amrubicin and vinorelbine as a second-line therapy for advanced non-small cell lung cancer (NSCLC) has not been fully evaluated. To determine the maximum tolerated dose (MTD) and recommended dose (RD), the present
Autor:
Atsushi Kaguchi, Tomomichi Ono, Seiji Tomiguchi, Shinya Shiraishi, Shigeto Matsushita, Toshiro Kageshita, Tsuyoshi Ishihara, Yasuyuki Yamashita
Publikováno v:
International journal of clinical oncology. 11(3)
The differentiation of true sentinel lymph nodes from nonsentinel lymph nodes is difficult in cases of multiple radiolabeled or dyed lymph nodes. We examined the locations of sentinel lymph nodes in melanoma and other malignant skin tumors by using d